Basel Medical Group LTD (BMGL) — 6-K Filings

All 6-K filings from Basel Medical Group LTD. Browse 21 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (21)

6-K Filing — Mar 30, 2026
Basel Medical Group Files Routine 6-K, Maintains SEC Compliance — Mar 24, 2026
Basel Medical Group Ltd filed a 6-K on March 24, 2026, which is a routine report for foreign private issuers to disclose material information. This specific fil
Basel Medical Receives Nasdaq Delinquency Notice — Dec 1, 2025 Risk: medium
Basel Medical Group Ltd. filed a Form 6-K on December 1, 2025, reporting the receipt of a delinquency notification from Nasdaq. The company's principal executiv
Basel Medical Group Appoints New Chief Commercial Officer — Aug 21, 2025 Risk: low
Basel Medical Group Ltd (Nasdaq: BMGL) announced the appointment of Mr. Tan Boon Chye (Darren) as its Chief Commercial Officer, effective August 15, 2025. Mr. T
Basel Medical Group Ltd Loses Chief Partnership Officer — Aug 13, 2025 Risk: medium
Basel Medical Group Ltd (Nasdaq: BMGL) announced on August 13, 2025, that its Group Chief Partnership Officer, Mr. Vincent Teo, has submitted his resignation. T
Basel Medical Group Halts BTC Digital Asset Acquisition — Jul 18, 2025 Risk: medium
Basel Medical Group Ltd announced on July 17, 2025, that it is putting on hold its acquisition of BTC Digital Asset. The company filed this report on July 18, 2
Basel Medical Group Appoints New Auditor — Jul 2, 2025 Risk: low
Basel Medical Group Ltd (Nasdaq: BMGL) announced on June 30, 2025, the appointment of NLA DFK Assurance PAC as its new independent registered public accounting
Basel Medical Secures Lock-Up Waiver for Fundraising — Jun 26, 2025 Risk: medium
Basel Medical Group Ltd announced on June 26, 2025, that it has obtained a waiver of its lock-up agreement. This waiver is a crucial step that potentially allow
Basel Medical Group Ltd Files 6-K with Financials — Jun 18, 2025 Risk: low
Basel Medical Group Ltd filed a Form 6-K on June 18, 2025, reporting unaudited consolidated financial statements and management's discussion for the six months
Basel Medical Group Ltd. Files May 2025 Report — Jun 3, 2025 Risk: low
Basel Medical Group Ltd. filed a Form 6-K on June 3, 2025, reporting for the month of May 2025. The filing includes a press release dated May 29, 2025. The comp
Basel Medical Group Signs Master Supply Agreement — May 22, 2025 Risk: low
On May 20, 2025, Basel Medical Group Ltd. (Nasdaq: BMGL) announced that its subsidiary, Basel Medical Group Pte Ltd, entered into a Master Supply Agreement with
Basel Medical Group Plans $1B Bitcoin Acquisition — May 16, 2025 Risk: high
Basel Medical Group Ltd announced on May 16, 2025, a strategic initiative to acquire up to US$1.0 billion in Bitcoin (BTC). This move signifies a significant sh
Basel Medical Completes Bethesda Acquisition — Apr 30, 2025 Risk: low
On April 11, 2025, Basel Medical Group Ltd (Nasdaq: BMGL), through its subsidiary BMGPL, entered into a sale and purchase agreement to acquire all ordinary shar
Basel Medical Group CEO Resigns, Interim Appointed — Apr 21, 2025 Risk: medium
On April 15, 2025, Basel Medical Group Ltd (Nasdaq: BMGL) announced the resignation of Raymond Cheung as Chief Executive Officer and a director. The board has a
Basel Medical Acquires Bethesda Medical — Apr 11, 2025 Risk: medium
On April 11, 2025, Basel Medical Group Ltd (Nasdaq: BMGL), through its subsidiary BMGPL, announced the acquisition of Bethesda Medical Pte. Ltd. from Silkroute
Basel Medical Group Appoints New Director — Apr 4, 2025 Risk: low
On April 4, 2025, Basel Medical Group Ltd appointed Mr. Keng Leong Fung (Raymond Fung) as a director to its Board. Mr. Fung was nominated by Rainforest Capital
Basel Medical Group Ltd to follow BVI governance over Nasdaq rules — Mar 25, 2025 Risk: medium
Basel Medical Group Ltd, incorporated in the British Virgin Islands, has notified Nasdaq of its intention to follow BVI corporate governance practices instead o
Basel Medical Group Ltd IPO Underwriting Agreement — Mar 19, 2025 Risk: low
On February 24, 2025, Basel Medical Group Ltd entered into an underwriting agreement with Cathay Securities, Inc., as representative for the underwriters. This
Basel Medical Group Ltd Closes IPO — Mar 6, 2025 Risk: medium
Basel Medical Group Ltd announced the closing of its initial public offering (IPO) on February 26, 2025. The company sold 2,205,000 ordinary shares as part of t
Basel Medical Group Ltd Closes Initial Public Offering — Mar 3, 2025 Risk: medium
Basel Medical Group Ltd announced the closing of its initial public offering (IPO) on March 3, 2025. The company entered into an underwriting agreement with Cat
Basel Medical Group Ltd Announces IPO Underwriting Agreement — Feb 28, 2025 Risk: medium
On February 24, 2025, Basel Medical Group Ltd entered into an underwriting agreement with Cathay Securities, Inc., acting as the representative for the underwri

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX